Mark T. Jennings

Intensive Care Medicine

1635 N George Mason Dr Ste 190
Arlington, VA 22205

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Effect of Elexacaftor/Tezacaftor/Ivacaftor Treatment on Extrapulmonary Complications of Cystic Fibrosis.

Effect of Elexacaftor/Tezacaftor/Ivacaftor Treatment on Extrapulmonary Complications of Cystic Fibrosis.

Journal: Advances in therapy

Published: December 12, 2025

Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis.

Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: December 05, 2025

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del-gating and F508del-residual function genotypes: results from an open-label extension study.

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del-gating and F508del-residual function genotypes: results from an open-label extension study.

Journal: Annals of the American Thoracic Society

Published: October 03, 2025

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial.

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial.

Journal: American journal of respiratory and critical care medicine

Published: August 11, 2025

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3 Open-Label Extension Study.

Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One F508del Allele: A Phase 3 Open-Label Extension Study.

Journal: American journal of respiratory and critical care medicine

Published: April 10, 2025

EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS.

EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: October 21, 2022

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.

Journal: American journal of respiratory and critical care medicine

Published: July 11, 2022

Vitamin D Deficiency Is Associated with Increased Nontuberculous Mycobacteria Risk in Cystic Fibrosis.

Vitamin D Deficiency Is Associated with Increased Nontuberculous Mycobacteria Risk in Cystic Fibrosis.

Journal: Annals of the American Thoracic Society

Published: November 17, 2020

Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations.

Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: October 16, 2020

Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy.

Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 17, 2020

Takotsubo Syndrome in the Setting of COVID-19.

Takotsubo Syndrome in the Setting of COVID-19.

Journal: JACC. Case reports

Published: April 16, 2020

Out-of-clinic measurement of sweat chloride using a wearable sensor during low-intensity exercise.

Out-of-clinic measurement of sweat chloride using a wearable sensor during low-intensity exercise.

Journal: NPJ digital medicine

Published: December 20, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026